Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
Clinical trial NCT04262466 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04262466
- Sponsor
- Immunocore Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-25
- Primary completion
- 2026-10-01
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.